In a review of 2014 [143], about amyloid-clearing proteins and their epigenetic regulation as a therapeutic target for AD, Turner et al. cited TTR as an amyloid protein with anti-Aβ amyloidogenic effect. The gene discussed is TTR; the disease is Alzheimer disease.